Blake Borgeson Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity
Blake Borgeson is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 6.65 Million shares of RXRX, which is worth approximately $27.5 Million. The most recent transaction as insider was on Apr 20, 2021, when has been sold 7,688,356 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
6.65M
6.21%
3M change
5.91%
12M change
Total Value Held
$27.5 Million
BB
Blake Borgeson
Director
Salt Lake City, UT